Sugi Predict

Sugi Predict / Compounds / SCHEMBL20071328

SCHEMBL20071328

SCHEMBL20071328

CN1CC2CC(C1)N2Cc1cnn(C)c1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 1/20 0.42
▸ OPRK1 P41145 1/20 0.42
▸ KCNH2 Q12809 4/20 0.39
▸ RET P07949 2/20 0.38
▸ ALDH1A1 P00352 1/20 0.37
▸ GABRA1 P14867 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ KAT2B Q92831 1/20 0.34
▸ PDE10A Q9Y233 2/20 0.34
▸ JAK2 O60674 1/20 0.33
▸ JAK1 P23458 1/20 0.33
▸ TYK2 P29597 1/20 0.33
▸ DRD2 P14416 1/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ GAA P10253 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20148694 0.84 RET (0.40) OPRM1OPRK1KCNH2RETALDH1A1
SCHEMBL20149633 0.84 OPRM1 (0.39) OPRM1OPRK1KCNH2RETALDH1A1
SCHEMBL22031246 0.83 RET (0.41) OPRM1OPRK1RETALDH1A1
SCHEMBL18390147 0.74 CHRM2 (0.58) ALDH1A1
SCHEMBL20154485 0.73 RET (0.40) RET
SCHEMBL22812025 0.73 ALDH1A1 (0.48) RETALDH1A1
SCHEMBL22030755 0.73 RET (0.39) RET
SCHEMBL22812010 0.73 RET (0.43) RETGABRA1GABRA5KAT2B
SCHEMBL22031240 0.73 RET (0.43) RETALDH1A1GABRA1GABRA5KDM4E
SCHEMBL18713232 0.73 CHRNB2 (0.47) OPRM1OPRK1KCNH2RETALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2024-02-29 — — US disclosed
US-10953005-B1 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2021-03-23 — — US disclosed
US-10172851-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors ARRAY BIOPHARMA INC. (US) 2019-01-08 — — US disclosed
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ARRAY BIOPHARMA INC. 2018-05-17 — — US disclosed
WO-2018071447-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS ANDREWS STEVEN W (US) 2018-04-19 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10953005-B1 Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors RET, ROR1, BRAF OPRM1 2992/4885OPRK1 1895/4885KCNH2 4165/4885
US-10172851-B2 Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors RET, ROR1, BRAF OPRM1 2992/4885OPRK1 1895/4885KCNH2 4165/4885
US-20180133213-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF OPRM1 2992/4885OPRK1 1895/4885KCNH2 4165/4885
US-20240066029-A1 SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS RET, ROR1, BRAF OPRM1 2992/4885OPRK1 1895/4885KCNH2 4165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.